23 September 2019, New York – Today at a high-level meeting at the United Nations (UN) headquarters, UN Member States adopted a political declaration on universal health coverage (UHC) that includes mention of rare diseases. This marks a hugely significant milestone for the rare disease community, with rare diseases being included for the first time within a UN declaration adopted by all 193 Member States.
In attendance at today’s meeting and representing the rare disease community were Yann Le Cam, Chief Executive Officer of EURORDIS-Rare Diseases Europe, member of the Council of Rare Diseases International (RDI) and member of the Executive Committee of the NGO Committee for Rare Diseases, and Durhane Wong-Rieger, Chair of the Council of RDI, President of the Canadian Organization for Rare Disorders and Member of the Board of the NGO Committee for Rare Diseases.
Contributing to the proceedings, EURORDIS-Rare Diseases Europe, RDI and the NGO Committee for Rare Diseases submitted a joint written statement outlining the case for including the 300 million people worldwide living with a rare disease within universal health coverage to ensure that this population is not left behind.
Also in attendance at today’s meeting were a number of key figures in international health policy, including Dr Tedros, Director-General of the World Health Organization (WHO), Ms Michelle Bachelet, UN High Commissioner for Human Rights and Mr Keizo Takemi, WHO UHC Goodwill Ambassador.
Durhane Wong-Rieger said, “The inclusion of people living with a rare disease within the declaration is the result of years of coordinated advocacy work from a number of organisations and led by Rare Diseases International, EURORDIS and the NGO Committee for Rare Diseases. The rare disease community remains committed to driving support for universal health coverage, to collaborating with relevant actors, to holding governments to account and to ensuring that traditionally left-behind communities like ours are actively engaged to plan, budget and implement the policies that will ensure services are more acceptable, appropriate and sustainable”.
Yann Le Cam commented, “This is the most important health-related text in the 15 years of the 2030 Agenda for Sustainable Development. It reinforces and creates a dynamic in almost all countries in the world to increase the percentage of the population (including people with rare diseases) benefitting from health coverage, enlarges the list of care services covered, and increases the percentage of healthcare expenses covered by public resources. The declaration gives us the most robust grounds to date to move towards a UN resolution on rare diseases”.
Anders Olauson, Chair of the NGO Committee and Chairman of the Ågrenska National Centre for Rare Diseases (Sweden), said, “This declaration represents a double milestone for the rare disease community. At a political level, the inclusion of rare diseases alongside communicable and non-communicable diseases, impairments and disabilities, means people living with rare diseases are no longer invisible t0 the international health policy agenda. At a practical level, the text also provides leverage for local stakeholders to call for national action to provide health services for people affected by a rare disease”.
EURORDIS, RDI and the NGO Committee for Rare Diseases have worked together over the last three years to advocate for people living with rare diseases to be included within universal health coverage. Recent advocacy actions include:
Rare Diseases International (RDI) is the global alliance of people living with a rare disease of all nationalities across all rare diseases. RDI’s mission is to be a strong common voice on behalf of rare disease patients around the world, to advocate for rare diseases as an international public health priority and to represent its members and enhance their capacities. RDI has more than 60 member organisations from over 30 countries, that in turn represent rare disease patient groups in more than 100 countries worldwide.
EURORDIS-Rare Diseases Europe is a unique, non-profit alliance of over 800 rare disease patient organisations from over 70 countries that work together to improve the lives of the 30 million people living with a rare disease in Europe. By connecting patients, families and patient groups, as well as by bringing together all stakeholders and mobilising the rare disease community, EURORDIS strengthens the patient voice and shapes research, policies and patient services.
The NGO Committee for Rare Diseases, created in 2015 by Ågrenska and EURORDIS-Rare Diseases Europe, is a Substantive Committee of the Conference of NGOs in Consultative Relationship with the United Nations (CoNGO). The NGO Committee is a multi-stakeholder, inclusive, global ecosystem, which works towards making rare diseases a global health priority on the UN’s agenda and within public health, research, medical and social care policies and structures around the world.